Semaglutide: what it does and what to watch
Also known as: GLP-1 receptor agonist, Incretin mimetic · GLP-1 receptor agonist · Updated 2026-08-20 · Educational — not medical advice
In plain language: This medicine mimics a natural gut hormone released after eating called GLP-1, and is designed to remain active in the body for an extended period. It boosts insulin release when blood sugar is high, dampens a hormone that raises blood sugar, and slows stomach emptying, which together lower blood sugar and increase feelings of fullness.
What it's used for
- Managing blood sugar in type 2 diabetes
- Supporting weight management in some adults with obesity or weight-related conditions
- Reducing cardiovascular risk in some adults with type 2 diabetes and existing heart disease
Common side effects
- Nausea
- Vomiting
- Diarrhea or constipation
- Reduced appetite
- Fatigue
Get medical help if…
Inflammation of the pancreas (pancreatitis), signalled by severe abdominal pain, sometimes radiating to the back
Gallbladder problems including gallstones, especially with rapid weight loss
Rare thyroid tumors seen in animal studies; the relevance to humans is not fully established but is treated as a caution
Worsening of diabetic eye disease has been reported when blood sugar drops quickly with treatment
Lab values it can move
Few guides tell you this part: medicines show up in blood work. If you take Semaglutide and a value below looks off on your report, this may be part of the story — never stop a medicine without your doctor.
This measure of average blood sugar control typically improves over months of treatment and is a key marker used to judge response.
HbA1cFasting blood sugar levels usually fall during treatment and are monitored regularly alongside other diabetes measures.
Fasting GlucoseBlood fat levels, including triglycerides, often improve alongside weight and blood sugar changes during treatment.
TriglyceridesGood to know
- Not used to treat type 1 diabetes or diabetic ketoacidosis, since it depends on the body's own remaining insulin response
- Nausea is common when starting or increasing the dose and usually eases with time; eating smaller, slower meals can help
- Seek prompt medical attention for severe, persistent abdominal pain, which could indicate pancreas or gallbladder involvement
- People with a personal or family history of certain thyroid tumors are usually advised against this medicine, based on findings in animal studies
- Report a lump or swelling in the neck, hoarseness, difficulty swallowing, or sudden changes in vision
Questions people ask
Is nausea from this medicine something to worry about?
Mild to moderate nausea is very common, especially when starting treatment or after a dose increase, and it usually eases within a few weeks as the body adjusts. Eating smaller, slower meals and avoiding very fatty or rich foods can help. Severe, persistent vomiting or abdominal pain, however, should be reported rather than managed alone.
Why is there a thyroid caution with this medicine?
In animal studies, medicines in this class were linked to a type of thyroid tumor arising from specific thyroid cells. Whether this risk applies to humans in the same way is not fully established, but as a precaution this medicine is generally avoided in people with a personal or family history of these particular thyroid tumors.
Taking Semaglutide? See what your blood work says.
Upload your lab report — every value checked and explained. Free — no account needed.